Bioenergy centres working towards biofuel goals

At present in India, there are three bioenergy centers established by the department of biotechnology (DBT) to ensure that long term targets of producing cost-effective biofuels are achieved through R&D

biofuel

Multi-disciplinary research to be conducted using cutting-edge technology

"Through R&D network projects, support is being given to Biohydrogen, Biobutanol and algal bio-fuels," stated the union minister of state for science and technology, Dr Jitendra Singh recently in the parliament.

The DBT has established three Bio-energy Centers including DBT-ICT Center for Energy Biosciences, Institute of Chemical Technology, Matunga, Mumbai, Maharashtra; DBT-IOC Centre for Advanced Bio-energy Research, R&D Center, Indian Oil Corporation Limited, Faridabad, Haryana and DBT-ICGEB Center for Advanced Bio-Energy Research, International Center for Genetic Engineering and Biotechnology (ICGEB), New Delhi.

The main objectives of the above three Bio-energy Centers are to conduct multi-disciplinary bio-energy research involving biology, chemical science and material science; develop technology for second generation bio-fuels; deploy bio-fuel technologies with existing capabilities to scale up and to perform cutting edge research using Synthetic and Systems biology approaches towards the development of novel technology for bio-fuel production.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

The Wells Fargo EGS Educathon 10K Run/Ride/Walk Event Marks Its Fifth Anniversary

Monday, 20 Feb 2017   |   Wells Fargo Enterprise Global Services (EGS) - India

Business Wire India More than 2,000 team members of Wells Fargo Enterprise Global Services (EGS) India

World's First Medically-Accurate Health Monitoring System Integrated in

Friday, 17 Feb 2017   |   Leman Micro Devices

Business Wire India Leman Micro Devices (LMD), the developer of accredited consumer healthcare products

US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment

Friday, 17 Feb 2017   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) approved

BusinessWire India.com - Pharmaceutical

Bwi-logo

Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.

Friday, 17 Feb 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) announced the completion

BusinessWire India.com - Medical Devices

Bwi-logo

World's First Medically-Accurate Health Monitoring System Integrated in

Friday, 17 Feb 2017   |   Leman Micro Devices

Business Wire India Leman Micro Devices (LMD), the developer of accredited consumer healthcare products

US FDA Expands Approval of Tiotropium Respimat® for Maintenance Treatment

Friday, 17 Feb 2017   |   Boehringer Ingelheim

Business Wire India Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) approved

Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.

Friday, 17 Feb 2017   |   Takeda Pharmaceutical Company Limited

Business Wire India Takeda Pharmaceutical Company Limited (TSE:4502) (“Takeda”) announced the completion

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email

X